Geerts A, De Prest B, Roels F
Histochemistry. 1984;80(4):339-45. doi: 10.1007/BF00495414.
The biosynthesis, transport and degradation of catalase have been studied in the guinea pig liver parenchymal cell using 2-allyl-2-isopropylacetamide (AIA) as an inhibitor of de novo formation of catalase. Total catalase activity was assayed biochemically; cytoplasmic catalase was measured microspectrophotometrically after quantitative diaminobenzidine staining of the liver. By morphometry, number and size of peroxisomes in catalase stained sections were determined. From our data we conclude that (1) the final step in the catalase formation takes place inside peroxisomes, (2) catalase is transported from the peroxisomes into the cytoplasm, (3) in the cytoplasm catalase is degraded. These conclusions in part confirm the topological model on the intracellular catalase biosynthesis pathway of Lazarow and de Duve (1973) except for the presence of cytoplasmic catalase which is released from the peroxisomes as proposed earlier by Jones and Masters (1975).
利用2-烯丙基-2-异丙基乙酰胺(AIA)作为过氧化氢酶从头合成的抑制剂,在豚鼠肝脏实质细胞中研究了过氧化氢酶的生物合成、转运和降解。通过生化方法测定过氧化氢酶的总活性;在对肝脏进行定量二氨基联苯胺染色后,用显微分光光度法测量细胞质中的过氧化氢酶。通过形态计量学,确定过氧化氢酶染色切片中过氧化物酶体的数量和大小。根据我们的数据,我们得出以下结论:(1)过氧化氢酶形成的最后一步发生在过氧化物酶体内;(2)过氧化氢酶从过氧化物酶体转运到细胞质中;(3)在细胞质中过氧化氢酶被降解。这些结论部分证实了Lazarow和de Duve(1973年)提出的细胞内过氧化氢酶生物合成途径的拓扑模型,但与Jones和Masters(1975年)早期提出的从过氧化物酶体释放细胞质过氧化氢酶的情况不同。